Synergistic regenerative effects of functionalized endometrial stromal cells with hyaluronic acid hydrogel in a murine model of uterine damage

Functional recovery of damaged uteri using HA/fibrin hydrogel. An injectable HA/fibrin hydrogel was manufactured and used to encapsulate in vitro decidualized EMSCs (dEMSCs) retrieved from parous mice. To produce a uterine synechia model, the endometrium underwent chemical damage. HA/fibrin hydrogel...

Full description

Saved in:
Bibliographic Details
Published in:Acta biomaterialia Vol. 89; pp. 139 - 151
Main Authors: Kim, Yoon Young, Park, Kyu-Hyung, Kim, Yong Jin, Kim, Moon Suk, Liu, Hung Ching, Rosenwaks, Zev, Ku, Seung-Yup
Format: Journal Article
Language:English
Published: England Elsevier Ltd 15-04-2019
Elsevier BV
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Functional recovery of damaged uteri using HA/fibrin hydrogel. An injectable HA/fibrin hydrogel was manufactured and used to encapsulate in vitro decidualized EMSCs (dEMSCs) retrieved from parous mice. To produce a uterine synechia model, the endometrium underwent chemical damage. HA/fibrin hydrogel with dEMSCs was grafted into the damaged uteri. Subsequent recovery was analyzed using in vitro and in vivo assays. Embryos were transferred into regenerated uteri, and implantation and embryonic development were evaluated. [Display omitted] Clinically intractable infertility and recurrent miscarriage due to irreversible endometrial damage need to be treated with biomaterial- and cell-based therapies. Some previous studies have reported on the efficacy of a collagen scaffold and/or bone marrow-derived mesenchymal stem cells. However, the functional differentiation of grafted cells was uncertain, and the time required for regeneration was long in these studies. Here, we show the synergistic regenerative effects of hyaluronic acid (HA) hydrogel with in vitro decidualized endometrial stromal cells (EMSCs) in a murine uterine infertility (synechiae) model. Decidualized EMSCs (dEMSCs) were encapsulated with HA hydrogel, combined with three different doses of fibrinogen/thrombin (5, 50, and 500 mIU/mL). The HA/fibrin gel showed biocompatibility when mixed with dEMSCs. The addition of thrombin enhanced gel formation (5 and 50 mIU/mL) and engraftment and enabled the effective release of adhesion molecules. Within two weeks, which is a short duration, treatment with hydrogel decreased the fibrous tissue and increased the thickness of the endometrium. The regenerated endometrium demonstrated functional recovery, as evidenced by the expression and secretion of molecules essential for embryonic implantation, such as Desmin, CD44, PECAM, and IGF-1. Transferred embryos successfully implanted and the normal development of implanted embryos (n = 37) were evaluated by co-localization of distinct markers of the three germ layers (Sox2, Nestin, Brachyury, AFP, and HNF4α). Live birth of offspring was achieved in the regenerated endometrium by HA hydrogel. Therefore, HA hydrogel-mixed dEMSCs can be an innovative treatment strategy with rapid recovery of endometrial damage and may also have therapeutic potential in intractable infertility or recurrent miscarriage. Decidualized EMSCs (dEMSCs) encapsulated with HA hydrogel combined with fibrinogen/thrombin (50 mIU/mL) showed injectability and biocompatibility when mixed with dEMSCs. Hydrogel-encapsulated dEMSCs can be a useful treatment for damaged endometrium in short duration, with successful implantation and normal development in a murine model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1742-7061
1878-7568
DOI:10.1016/j.actbio.2019.03.032